Chronic myelogenous leukemia (CML) is an insidious cancer.

FORBES: The Race for a Cure

Antigenics ' (nasdaq: AGEN - news - people ) decision to test the drug in chronic myelogenous leukemia (CML), a rare disease developed by more than 4, 000 adults per year, is emblematic of a trend in drug development.

FORBES: Magazine Article